NCT04334590

Brief Summary

There is a robust body of research suggesting that the use of pre-surgical orthopedic devices prior to definitive cleft lip/nose repair results in significant improvement of facial aesthetics with long term follow up. However, in recent surveys of the cleft centers in the US, only 30% of cleft centers offer PSIOs, and only 13% routinely report its use. Accordingly, thirty percent of centers utilize a two-stage cleft lip/nose repair in the centers' algorithm (1st: lip adhesion; 2nd: final lip repair). The major drawback to a two-stage cleft procedure is the administration of two general anesthetics to an infant before the age of one year. There is a growing amount of evidence that multiple anesthetic experiences before a certain age could affect brain development. It is difficult to make inferences as to why clinicians are not utilizing surgical aids to decrease the size of the cleft width, but even when PSIO is offered, caregivers experience additional, potentially prohibitive challenges. In one study, caregivers traveled an average of 70 miles to visit the nearest cleft center offering pre-surgical orthopedic devices. As these devices are created by hand every 1-2 weeks after seeing the child in clinic, parents are required to travel to clinic multiple times per month. Not surprisingly, infants who were first-born and those who did not have other siblings were more likely to receive pre-surgical orthopedic treatment than infants who were residing with other siblings. Given the benefits of PSIOs and the barriers both to healthcare systems and patients' families associated with PSIOs in its current form, a new form of pre-surgical clinical management is needed. Objectives:

  1. 1.Evaluate JHH's current clinical performance in addressing unilateral cleft lip and nasal deformity.
  2. 2.Elucidate the difference in preoperative cleft size and in surgical management/outcomes for patients who received PSIOs through 3D-printed devices.
  3. 3.Using the above maxillofacial growth data with and without PSIOs, the investigators aim to create an algorithm to predict maxillofacial growth for each individual patient to design pre-sequenced custom PSIO devices.

Trial Health

30
At Risk

Trial Health Score

Automated assessment based on enrollment pace, timeline, and geographic reach

Trial has exceeded expected completion date
Timeline
Completed

Started Jun 2020

Geographic Reach
1 country

1 active site

Status
withdrawn

Health score is calculated from publicly available data and should be used for screening purposes only.

Trial Relationships

Click on a node to explore related trials.

Study Timeline

Key milestones and dates

First Submitted

Initial submission to the registry

April 2, 2020

Completed
4 days until next milestone

First Posted

Study publicly available on registry

April 6, 2020

Completed
2 months until next milestone

Study Start

First participant enrolled

June 8, 2020

Completed
1.8 years until next milestone

Primary Completion

Last participant's last visit for primary outcome

April 1, 2022

Completed
Same day until next milestone

Study Completion

Last participant's last visit for all outcomes

April 1, 2022

Completed
Last Updated

August 21, 2023

Status Verified

August 1, 2023

Enrollment Period

1.8 years

First QC Date

April 2, 2020

Last Update Submit

August 17, 2023

Conditions

Keywords

Cleft Lip

Outcome Measures

Primary Outcomes (3)

  • Percentage of cleft patients with an alveolar cleft of <5 mm at time of the first surgery

    Percentage of cleft patients with an alveolar cleft of \<5 mm at time of the first surgery will be assessed to determine the effect of 3D printed orthognathic pre-surgical molding devices on cleft care.

    At the time of first surgery (3 months)

  • Cleft size at initial clinic presentation

    Cleft size in millimeters (mm) at initial clinic presentation.

    At the time of initial clinic visit up to 1 hour

  • Size of cleft at pre- and post-operative clinic visit

    Size of cleft in millimeters at pre- and post-operative clinic visit

    At pre- and post-operative clinic visit, up to 4 months

Secondary Outcomes (4)

  • Rate of change in cleft size

    Weekly, up 8 weeks

  • Length of time to achieve a cleft <5 mm

    Up to 4 months

  • Aesthetic outcome following cleft surgical repair as assessed by the surgeon

    Post surgery, up to 4 months

  • Satisfaction with the 3-D printed pre-surgical orthopedic device as assessed by parents

    Post surgery, up to 4 months

Study Arms (2)

Cleft Lip/Nose Repair without PSIO

Participants who will undergo cleft lip/nose repair prior to addition of PSIO as part of standard of care in Hopkins.

Procedure: Cleft Lip/Nose Repair without PSIO

Presurgical Infant Orthopedic Therapy

Participants who will undergo cleft lip/nose repair after addition of PSIO as part of standard of care in Hopkins.

Procedure: Presurgical Infant Orthopedic Therapy

Interventions

Standard of care surgical repair of cleft lip/nose without PSIO.

Cleft Lip/Nose Repair without PSIO

Standard of care surgical repair of cleft lip/nose with PSIO.

Presurgical Infant Orthopedic Therapy

Eligibility Criteria

Age0 Months - 1 Month
Sexall
Healthy VolunteersNo
Age GroupsChild (0-17)
Sampling MethodNon-Probability Sample
Study Population

Newborns either born in Johns Hopkins or presenting to clinic with a cleft lip between 0-1 months of life.

You may qualify if:

  • All newborns either born in Johns Hopkins or presenting to clinic with a cleft lip between 0-1 months of life

You may not qualify if:

  • Patients older than one month of age at presentation

Contact the study team to confirm eligibility.

Sponsors & Collaborators

Study Sites (1)

Johns Hopkins Hospital

Baltimore, Maryland, 21287, United States

Location

MeSH Terms

Conditions

Cleft LipCongenital AbnormalitiesNose Deformities, Acquired

Condition Hierarchy (Ancestors)

Lip DiseasesMouth DiseasesStomatognathic DiseasesMouth AbnormalitiesStomatognathic System AbnormalitiesCongenital, Hereditary, and Neonatal Diseases and AbnormalitiesNose DiseasesRespiratory Tract DiseasesOtorhinolaryngologic Diseases

Study Officials

  • Richard Redett

    Johns Hopkins University

    PRINCIPAL INVESTIGATOR
0

Study Design

Study Type
observational
Observational Model
COHORT
Time Perspective
PROSPECTIVE
Sponsor Type
OTHER
Responsible Party
SPONSOR

Study Record Dates

First Submitted

April 2, 2020

First Posted

April 6, 2020

Study Start

June 8, 2020

Primary Completion

April 1, 2022

Study Completion

April 1, 2022

Last Updated

August 21, 2023

Record last verified: 2023-08

Locations